Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Colonialist accusations, trust issues, and not caring what Open AI is producing - AI ethicist Stephanie Antonian raises some ...

The goal is audacious, developing AGI that can match and eventually exceed human performance, across wide range of tasks, ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

When someone starts a new job, early training may involve shadowing a more experienced worker and observing what they do ...

Young people do not trust that a story is credible simply because an expert, editorial gatekeeper, or other authority figure ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

What L’Oréal and Microsoft’s AI strategies reveal about the future of beauty and marketing from empowering creators to ...